e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is nailfold videocapillaroscopy a valuable diagnostic tool in pulmonary hypertension?
F. Meier, M. Geyer, H. Tiede, A. Rieth, H.A. Ghofrani, U. Müller-Ladner, R. Dinser, W. Hermann (Bad Nauheim, Giessen, Germany)
Source:
Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Session:
Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Session type:
Thematic Poster Session
Number:
972
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Meier, M. Geyer, H. Tiede, A. Rieth, H.A. Ghofrani, U. Müller-Ladner, R. Dinser, W. Hermann (Bad Nauheim, Giessen, Germany). Is nailfold videocapillaroscopy a valuable diagnostic tool in pulmonary hypertension?. Eur Respir J 2012; 40: Suppl. 56, 972
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
A simple non-invasive diagnostic algorithm for pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009
The clinical role of routine non-invasive parameters in the diagnostic work-up of patients with risk for pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Year: 2012
Validation of a non-invasive diagnostic algorithm in assessment of patients with clinical suspicion of pulmonary embolism
Source: Eur Respir J 2002; 20: Suppl. 38, 238s
Year: 2002
A noninvasive algorithm to exclude pre-capillary pulmonary hypertension
Source: Eur Respir J 2011; 37: 1096-1103
Year: 2011
Evaluation of recently validated non-invasive formula using basic lung functions as a new screening tool for pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Cardiac bioimpedance as a non-invasive tool in patients with pulmonary hypertension
Source: Annual Congress 2011 - Innovative methods in exercise testing
Year: 2011
A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension
Source: Eur Respir J, 56 (3) 2000513; 10.1183/13993003.00513-2020
Year: 2020
Noninvasive assessment of pulmonary circulation in scleroderma patients
Source: Annual Congress 2005 - Exercise in pulmonary hypertension
Year: 2005
Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease
Source: ERJ Open Res, 8 (1) 00549-2021; 10.1183/23120541.00549-2021
Year: 2022
Combining physiology and imaging in the diagnosis of pulmonary hypertension
Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines
Year: 2019
Gamma-Glutamyltransferase in pulmonary hypertension: A reliable biomarker?
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Non-invasive evaluation in prediction of pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Non-invasive hemodynamic assessment in patients with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
Towards prognostic biomarkers in pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 799-801
Year: 2012
The role of echocardiography in the diagnosis and management of patients with pulmonary hypertension
Source: Eur Respir Rev 2010 19: 288-299
Year: 2010
Validation of a novel prognostic tool for idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
Lung ultrasound as useful tool to diagnose pulmonary atelectasis in children affected by neuromuscular disease
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018
Echocardiography for the diagnosis of pulmonary vascular disease
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Noninvasive estimation of PVR using contrast enhanced MRI in patients with idiopathic pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept